Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | AKR1C3 | P42330 | 12/20 | 0.62 |
| ▸ | AKR1C2 | P52895 | 12/20 | 0.62 |
| ▸ | GFER | P55789 | 1/20 | 0.62 |
| ▸ | NGLY1 | Q96IV0 | 1/20 | 0.62 |
| ▸ | FABP4 | P15090 | 1/20 | 0.61 |
| ▸ | AKR1C4 | P17516 | 3/20 | 0.59 |
| ▸ | AKR1C1 | Q04828 | 3/20 | 0.59 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.59 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.56 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.51 |
| ▸ | RHOA | P61586 | 1/20 | 0.50 |
| ▸ | CTSV | O60911 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29071829 | 0.90 | AKR1C3 (0.72) | AKR1C3AKR1C2AKR1C4AKR1C1AKR1B10 | |
| SCHEMBL2425054 | 0.88 | MAPT (0.62) | MAPTKDM4EALDH1A1GAATHRB | |
| SCHEMBL4640305 | 0.85 | MAPT (0.72) | MAPTKDM4EALDH1A1GAATHRB | |
| SCHEMBL3237539 | 0.85 | AKR1C3 (0.67) | MAPTKDM4EALDH1A1GAATHRB | |
| SCHEMBL7093800 | 0.85 | AKR1C3 (0.65) | MAPTAKR1C3AKR1C2AKR1C4AKR1C1 | |
| SCHEMBL31150705 | 0.84 | AKR1C3 (0.69) | MAPTKDM4EALDH1A1GAATHRB | |
| SCHEMBL7869107 | 0.84 | AKR1C3 (0.67) | KDM4EHPGDAKR1C3AKR1C2GFER | |
| SCHEMBL28968868 | 0.84 | AKR1C3 (0.50) | MAPTKDM4EALDH1A1GAATHRB | |
| SCHEMBL7113569 | 0.84 | AKR1C3 (0.57) | MAPTKDM4EALDH1A1GAATHRB | |
| SCHEMBL28472949 | 0.84 | AKR1C3 (0.64) | MAPTKDM4EALDH1A1GAATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199653-A1 | METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-06-20 | — | — | US | claimed |
| CN-116218167-B | Antistatic master batch, antistatic polyester film and preparation method thereof | 合肥长阳新材料科技有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-116218167-A | Antistatic master batch, antistatic polyester film and preparation method thereof | 合肥长阳新材料科技有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-104072403-B | A kind of method preparing compound UNC1215 | CHENGDU UNIVERSITY (CN) | 2016-04-13 | — | — | CN | claimed |
| US-8968454-B2 | Magenta quinacridone pigments | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-03-03 | — | — | US | claimed |
| CN-104072403-A | Method for preparing compound UNC1215 | UNIV CHENGDU | 2014-10-01 | — | — | CN | claimed |
| EP-2556117-A1 | NEW MAGENTA QUINACRIDONE PIGMENTS | Clariant Finance (BVI) Limited (VG) | 2013-02-13 | — | — | EP | claimed |
| US-20130029265-A1 | New Magenta Quinacridone Pigments | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-01-31 | — | — | US | claimed |
| EP-2374848-B1 | New magenta quinacridone pigments | CLARIANT FINANCE BVI LTD (VG) | 2013-01-16 | — | — | EP | claimed |
| CN-102762666-A | Novel magenta quinacridone pigments | CLARIANT INTERNAT BVI LTD | 2012-10-31 | — | — | CN | claimed |
| WO-2011124327-A1 | NEW MAGENTA QUINACRIDONE PIGMENTS | CLARIANT INTERNATIONAL LTD (CH) | 2011-10-13 | — | — | WO | claimed |
| EP-2374848-A1 | New magenta quinacridone pigments | Clariant International Ltd. (CH) | 2011-10-12 | — | — | EP | claimed |
| US-4099980-A | Process for producing gamma quinacridone solid solutions | HARMON COLORS CORPORATION (US) | 1978-07-11 | — | — | US | claimed |
| US-3940399-A | Process for the production of gamma quinacridone | ALLIED CHEMICAL CORPORATION (US) | 1976-02-24 | — | — | US | claimed |
| US-12516071-B2 | Method for forming an electrically conductive metal organic framework composite | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-06 | — | — | US | disclosed |
| US-20250346585-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| CN-116063688-B | Flexible metal-organic framework material and preparation method thereof | 广东美的白色家电技术创新中心有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-4099980-A | Process for producing gamma quinacridone solid solutions | HARMON COLORS CORPORATION (US) | 1978-07-11 | — | — | US | disclosed |
| US-3940399-A | Process for the production of gamma quinacridone | ALLIED CHEMICAL CORPORATION (US) | 1976-02-24 | — | — | US | disclosed |
| US-3940399-A | Process for the production of gamma quinacridone | ALLIED CHEMICAL CORPORATION (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346585-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | C5, C1S, C9 | MAPT 1464/4885KDM4E 4647/4885ALDH1A1 1707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.